11/12
03:30 pm
cor
2 drug companies to pay $260M after jury finds them liable for city's opioid crisis [CBS News]
Low
Report
2 drug companies to pay $260M after jury finds them liable for city's opioid crisis [CBS News]
11/7
01:41 pm
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Robert W. Baird from $287.00 to $292.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Robert W. Baird from $287.00 to $292.00. They now have an "outperform" rating on the stock.
11/7
11:20 am
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at UBS Group AG from $275.00 to $285.00. They now have a "buy" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at UBS Group AG from $275.00 to $285.00. They now have a "buy" rating on the stock.
11/7
09:51 am
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Barclays PLC from $263.00 to $290.00. They now have an "overweight" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Barclays PLC from $263.00 to $290.00. They now have an "overweight" rating on the stock.
11/7
09:00 am
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Evercore ISI from $250.00 to $285.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Evercore ISI from $250.00 to $285.00. They now have an "outperform" rating on the stock.
11/6
06:37 am
cor
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results [Yahoo! Finance]
Medium
Report
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results [Yahoo! Finance]
11/6
06:35 am
cor
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
Medium
Report
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
11/6
06:30 am
cor
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
Medium
Report
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
11/4
08:30 am
cor
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
Low
Report
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
10/8
01:39 pm
cor
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Evercore ISI from $270.00 to $250.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Evercore ISI from $270.00 to $250.00. They now have an "outperform" rating on the stock.
10/7
09:17 am
cor
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Leerink Partners from $277.00 to $275.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Leerink Partners from $277.00 to $275.00. They now have an "outperform" rating on the stock.
10/1
07:30 am
cor
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
Low
Report
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
9/20
11:31 pm
cor
Cencora, Inc. (NYSE: COR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Cencora, Inc. (NYSE: COR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
9/18
08:05 am
cor
Cencora, Inc. (NYSE: COR) had its "neutral" rating re-affirmed by analysts at Bank of America Co.. They now have a $245.00 price target on the stock, down previously from $275.00.
Low
Report
Cencora, Inc. (NYSE: COR) had its "neutral" rating re-affirmed by analysts at Bank of America Co.. They now have a $245.00 price target on the stock, down previously from $275.00.
9/10
08:00 am
cor
Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team
Low
Report
Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team
9/6
08:08 am
cor
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Robert W. Baird from $287.00 to $283.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Robert W. Baird from $287.00 to $283.00. They now have an "outperform" rating on the stock.
8/21
10:09 am
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $287.00. They now have an "overweight" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $287.00. They now have an "overweight" rating on the stock.
8/15
07:30 am
cor
Cencora Elects Frank Clyburn to Its Board of Directors
Low
Report
Cencora Elects Frank Clyburn to Its Board of Directors